NEUE — Neuehealth Income Statement
0.000.00%
Last trade - 00:00- $58.85m
- $228.75m
- $936.66m
- 18
- 72
- 100
- 68
Annual income statement for Neuehealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Premiums Earned | |||||
| Net Investment Income | |||||
| Realized & Unrealized Gains / Losses | |||||
| Other Revenue | |||||
| Total Revenue | 515 | 1,513 | 751 | 1,161 | 937 |
| Losses, Benefits, and Adjustments | |||||
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 685 | 1,857 | 1,120 | 1,738 | 1,014 |
| Operating Profit | -170 | -344 | -369 | -577 | -77.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -170 | -350 | -382 | -629 | -99.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -161 | -323 | -385 | -628 | -102 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -248 | -1,185 | -1,456 | -1,151 | -135 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -248 | -1,185 | -1,495 | -1,201 | -186 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -20.5 | -67 | -60.2 | -35.5 | -20.9 |
| Dividends per Share |